Cargando…
Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
PURPOSE: To study target-specific delivery of doxorubicin (Dox) using an RNA aptamer against epithelial cell adhesion molecule (EpCAM) in retinoblastoma (RB) cells. METHODS: The binding affinity of the EpCAM aptamer to RB primary tumor cells, Y79 and WERI-Rb1 cells, and Müller glial cell lines were...
Autores principales: | Subramanian, Nithya, Raghunathan, Vaishnavi, Kanwar, Jagat R., Kanwar, Rupinder K., Elchuri, Sailaja V., Khetan, Vikas, Krishnakumar, Subramanian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513190/ https://www.ncbi.nlm.nih.gov/pubmed/23213278 |
Ejemplares similares
-
Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging
por: Subramanian, Nithya, et al.
Publicado: (2016) -
EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
por: Subramanian, Nithya, et al.
Publicado: (2015) -
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2015) -
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2020) -
RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma
por: Subramanian, Nithya, et al.
Publicado: (2013)